Detalhe da pesquisa
1.
Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations.
Nat Immunol;
22(12): 1503-1514, 2021 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34716452
2.
Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity.
J Virol;
97(7): e0159622, 2023 07 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37395646
3.
Correction: RV144 HIV-1 vaccination impacts post-infection antibody responses.
PLoS Pathog;
17(3): e1009386, 2021 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33651828
4.
Zika purified inactivated virus (ZPIV) vaccine reduced vertical transmission in pregnant immunocompetent mice.
NPJ Vaccines;
9(1): 32, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38360793
5.
Protective efficacy of a Zika purified inactivated virus vaccine candidate during pregnancy in marmosets.
NPJ Vaccines;
9(1): 35, 2024 Feb 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38368443
6.
Contemporary HIV-1 consensus Env with AI-assisted redesigned hypervariable loops promote antibody binding.
Nat Commun;
15(1): 3924, 2024 May 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38724518
7.
Mosaic vaccine-induced antibody-dependent cellular phagocytosis associated with delayed HIV-1 viral load rebound post treatment interruption.
Cell Rep;
43(6): 114344, 2024 Jun 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38850529
8.
Antibody targeting of conserved sites of vulnerability on the SARS-CoV-2 spike receptor-binding domain.
Structure;
32(2): 131-147.e7, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38157856
9.
Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques.
Nat Commun;
15(1): 200, 2024 Jan 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38172512
10.
Priming with Japanese encephalitis virus or yellow fever virus vaccination led to the recognition of multiple flaviviruses without boosting antibody responses induced by an inactivated Zika virus vaccine.
EBioMedicine;
97: 104815, 2023 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37793212
11.
Convalescent human IgG, but not IgM, from COVID-19 survivors confers dose-dependent protection against SARS-CoV-2 replication and disease in hamsters.
Front Immunol;
14: 1138629, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37026013
12.
Zika-specific neutralizing antibodies targeting inter-dimer envelope epitopes.
Cell Rep;
42(8): 112942, 2023 08 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37561630
13.
Bivalent intra-spike binding provides durability against emergent Omicron lineages: Results from a global consortium.
Cell Rep;
42(1): 112014, 2023 01 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36681898
14.
Fc receptor engagement of HIV-1 Env-specific antibodies in mothers and infants predicts reduced vertical transmission.
Front Immunol;
13: 1051501, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36578481
15.
Unglycosylated Soluble SARS-CoV-2 Receptor Binding Domain (RBD) Produced in E. coli Combined with the Army Liposomal Formulation Containing QS21 (ALFQ) Elicits Neutralizing Antibodies against Mismatched Variants.
Vaccines (Basel);
11(1)2022 Dec 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36679887
16.
B cell engagement with HIV-1 founder virus envelope predicts development of broadly neutralizing antibodies.
Cell Host Microbe;
29(4): 564-578.e9, 2021 04 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33662277
17.
RV144 vaccine imprinting constrained HIV-1 evolution following breakthrough infection.
Virus Evol;
7(2): veab057, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34532060
18.
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity.
Cell Rep;
37(12): 110143, 2021 12 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34919799
19.
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity.
bioRxiv;
2021 May 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34013273
20.
A high-throughput multiplex assay to characterize flavivirus-specific immunoglobulins.
J Immunol Methods;
487: 112874, 2020 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33022219